Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway

References

• Andersen S, Nielsen-Kudsk JE, Vonk Noordegraaf A, de Man FS. 2019. Right ventricular fibrosis. Circulation. 139:269–285.
   PubMed Web of Science ®Google Scholar
• Archer SL, Marsboom G, Kim GH, Zhang HJ, Toth PT, Svensson EC, Dyck JR, Gomberg-Maitland M, Thebaud B, Husain AN, et al. 2010. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation. 121(24):2661–2671.
   PubMed Web of Science ®Google Scholar
• Awad KS, West JD, de Jesus Perez V, MacLean M. 2016. Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series). Pulm Circ. 6(3):285–294.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang W, Jiang M, Yang M, Wei W. 2020. Combination therapy of ginsenoside compound K and methotrexate was efficient in elimination of anemia and reduction of disease activity in adjuvant-induced arthritis rats. Pharm Biol. 58:1131–1139.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Xing D. 2019. Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221. Eur Pharmacol. 853:353–363.
   PubMed Web of Science ®Google Scholar
• Crosswhite P, Sun Z. 2014. Molecular mechanisms of pulmonary arterial remodeling. Mol Med. 20:191–201.
   PubMed Web of Science ®Google Scholar
• Daneva Z, Laubach VE, Sonkusare SK. 2019. Novel regulators and targets of redox signaling in pulmonary vasculature. Curr Opinion Physiol. 9:87–93.
   PubMed Web of Science ®Google Scholar
• Dang Z, Su S, Jin G, Nan X, Ma L, Li Z, Lu D, Ge R. 2020. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat. J Ethnopharmacol. 250:112470.
   PubMed Web of Science ®Google Scholar
• Fessel JP, West JD. 2015. Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series). Pulm Circ. 5:599–609.
   PubMed Web of Science ®Google Scholar
• Gao L, Li SD, Zhang Y, Liu Y, Yang MH. 2020. Early intervention of Tongxinluo on right ventricular function assessed by echocardiography in rats with pulmonary arterial hypertension induced by monocrotaline. Chinese J Integrative Med. 26(12):913–920.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhu Y, Mao Y, Xu J, He X, Huang S, Wang M, Qiu J. 2020. Efficacy and safety of sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: a meta-analysis. Life Sci. 257:118001.
   PubMed Web of Science ®Google Scholar
• Hu G, Song Y, Ke S, Cao H, Zhang C, Deng G, Yang F, Zhou S, Liu P, Guo X, et al. 2017. Tanshinone IIA protects against pulmonary arterial hypertension in broilers. Poultry Sci. 96(5):1132–1138.
   PubMed Web of Science ®Google Scholar
• Huertas A, Perros F, Tu L, Cohen-Kaminsky S, Montani D, Dorfmuller P, Guignabert C, Humbert M. 2014. Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay. Circulation. 129:1332–1340.
   PubMed Web of Science ®Google Scholar
• Kolli-Bouhafs K, Boukhari A, Abusnina A, Velot E, Gies JP, Lugnier C, Ronde P. 2012. Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation. Invest New Drugs. 30(6):2121–2131.
   PubMed Web of Science ®Google Scholar
• Li L, Wei C, Kim IK, Janssen-Heininger Y, Gupta S. 2014. Inhibition of nuclear factor-kappaB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice. Hypertension. 63:1260–1269.
   PubMed Web of Science ®Google Scholar
• Li W, Guo A, Wang L, Kong Q, Wang R, Han L, Zhao C. 2016. Expression of peptide fragments from proADM and involvement of mitogen-activated protein kinase signaling pathways in pulmonary remodeling induced by high pulmonary blood flow. Congenital Anomalies. 56:28–34.
   PubMed Web of Science ®Google Scholar
• Montani D, Chaumais MC, Guignabert C, Gunther S, Girerd B, Jais X, Algalarrondo V, Price LC, Savale L, Sitbon O, et al. 2014. Targeted therapies in pulmonary arterial hypertension. Pharmacol Therap. 141:172–191.
   PubMed Web of Science ®Google Scholar
• Nan X, Su S, Ma K, Ma X, Wang X, Zhaxi D, Ge R, Li Z, Lu D. 2018. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. J Ethnopharmacol. 216:175–183.
   PubMed Web of Science ®Google Scholar
• Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM. 2004. Pathologic assessment of vasculopathies in pulmonary hypertension. J Amer Coll Cardiol. 43:25S–32S.
   PubMed Web of Science ®Google Scholar
• Rashid J, Nozik-Grayck E, McMurtry IF, Stenmark KR, Ahsan F. 2019. Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling. Am J Physiol Lung Cell Mol Physiol. 316:L119–L130.
   PubMed Web of Science ®Google Scholar
• Sakao S, Tatsumi K. 2011. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities. Int J Cardiol. 147:4–12.
   PubMed Web of Science ®Google Scholar
• Salimiaghdam N, Singh L, Schneider K, Nalbandian A, Chwa M, Atilano SR, Bao A, Kenney MC. 2020. Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines. BMJ Open Ophthalmol. 5:e000458.
   PubMed Web of Science ®Google Scholar
• Shao XS. 2013. Clinical observation of xinmai an tablet in the treatment of premature ventricular beats of coronary heart disease. J Liaoning Univ Trad Chinese Med. 15(09):183–185.
   Google Scholar
• Shen Q, Chen W, Liu J, Liang Q. 2019. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease. Life Sci. 232:116546.
   PubMed Web of Science ®Google Scholar
• Sluiter I, van Heijst A, Haasdijk R, Kempen MB, Boerema-de Munck A, Reiss I, Tibboel D, Rottier RJ. 2012. Reversal of pulmonary vascular remodeling in pulmonary hypertensive rats. Exper Mol Pathol. 93(1):66–73.
   PubMed Web of Science ®Google Scholar
• Tantini B, Manes A, Fiumana E, Pignatti C, Guarnieri C, Zannoli R, Branzi A, Galie N. 2005. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. Basic Res Cardiol. 100:131–138.
   PubMed Web of Science ®Google Scholar
• Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR. 2012. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J. 40:1555–1565.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu J, Zhao X, Xie W, Wang H, Kong H. 2018. Fasudil inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2. Exper Cell Res. 365:97–105.
   PubMed Web of Science ®Google Scholar
• Wang P, Li J, Zhang C, Luo L, Ni S, Tang Z. 2019. bFGF overexpression adipose derived mesenchymal stem cells improved the survival of pulmonary arterial endothelial cells via PI3k/Akt signaling pathway. Int J Biochem Cell Biol. 113:87–94.
   PubMed Web of Science ®Google Scholar
• Xiao XL, Hu N, Zhang XZ, Jiang M, Chen C, Ma R, Ma ZG, Gao JL, Xuan XC, Sun ZJ, et al. 2018. Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries. Brit J Pharmacol. 175:1707–1718.
   PubMed Web of Science ®Google Scholar
• Xu J, Wang J, He M, Han H, Xie W, Wang H, Kong H. 2018. Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension. Lab Inves. 98:1333–1346.
   PubMed Web of Science ®Google Scholar
• Zangiabadi A, De Pasquale CG, Sajkov D. 2014. Pulmonary hypertension and right heart dysfunction in chronic lung disease. BioMed Res Int. 2014:739674.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lv W, Piao H, Chu X, Wang H. 2014. Role of platelet-derived growth factor-BB (PDGF-BB) in human pulmonary artery smooth muscle cell proliferation. J Receptor Signal Transd Res. 34:254–260.
   PubMed Web of Science ®Google Scholar
• Zheng M, Zhao M, Tang L, Zhang C, Song L, Wang W. 2016. Ginsenoside Rg1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of p38. J Thorac Dis. 8(7):1513–1523.
   PubMed Web of Science ®Google Scholar
• Zhu YL, Sun YB, Zhang SC, Zhao YW, Zhao BX, Liu SJ, Li GF. 2021. Study on quality control of Xinmai 'an extract based on fingerprint and multi-index quantitative determination combined with chemical identification mode. J Chinese Med Mat. 1:18–20.
   Google Scholar